News Website

Hollyoaks star shares how she copes with painful illness while filming - MSN

Hollyoaks star shares how she copes with painful illness while filming MSN

Published: Oct. 24, 2024, 9:50 p.m.

Read Full Article

Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma

Hope Medicine touts favourable mid-stage data for endometriosis therapy FirstWord Pharma

Published: Oct. 24, 2024, 9:31 p.m.

Read Full Article

Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn

Racial disparities in high-risk endometrial subtype diagnoses reported Contemporary Obgyn

Published: Oct. 24, 2024, 6:26 p.m.

Read Full Article

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive

Published: Oct. 24, 2024, 3:55 p.m.

Read Full Article

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer Medscape

Published: Oct. 24, 2024, 1:44 p.m.

Read Full Article

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace

Published: Oct. 24, 2024, 11:46 a.m.

Read Full Article

Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com

Published: Oct. 24, 2024, 10:45 a.m.

Read Full Article

‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? - Medscape

‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? Medscape

Published: Oct. 24, 2024, 9:51 a.m.

Read Full Article

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.

Read Full Article

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire

Published: Oct. 24, 2024, 12:08 a.m.

Read Full Article

Latest Articles

Hollyoaks star shares how she copes with painful illness while filming - MSN

Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma

Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? - Medscape

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Subscribe to Our Newsletter